Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
Huju Chi, Chunman Li, Flora Sha Zhao, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

Cancer Cell Membrane-Coated Nanoparticle Co-loaded with Photosensitizer and Toll-like Receptor 7 Agonist for the Enhancement of Combined Tumor Immunotherapy
Yanlin Chen, Siying Zhi, Jiaxin Ou, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16620-16632
Closed Access | Times Cited: 38
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
Emily B. Wolf, Guilherme Sacchi de Camargo Correia, Shenduo Li, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 128-128
Open Access | Times Cited: 1
Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation
Pedro Paulo Chaves de Souza, Ulf H. Lerner
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 66
Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
Solmaz Ohadian Moghadam, Mohammad Reza Nowroozi
Scandinavian Journal of Immunology (2019) Vol. 90, Iss. 6
Open Access | Times Cited: 63
Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects
M. Brittany Johnson, Morgan Chandler, Kirill A. Afonin
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 427-438
Open Access | Times Cited: 52
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34
5-FU mediated depletion of myeloid suppressor cells enhances T-cell infiltration and anti-tumor response in immunotherapy–resistant lung tumor
Ambily Anna Mathew, Zahara Thaivalappil Zakkariya, Anusha Ashokan, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110129-110129
Closed Access | Times Cited: 17
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
Candido G. Da Silva, Marcel Camps, Tracy Li, et al.
Theranostics (2019) Vol. 9, Iss. 22, pp. 6485-6500
Open Access | Times Cited: 53
Nucleotide‐binding and oligomerization domain (NOD)‐like receptors in teleost fish: Current knowledge and future perspectives
Liang Zhang, Zhuying Gao, Li Yu, et al.
Journal of Fish Diseases (2018) Vol. 41, Iss. 9, pp. 1317-1330
Closed Access | Times Cited: 52
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Hua Zhang, Wei-Lun Tang, Azadeh Kheirolomoom, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 1080-1094
Open Access | Times Cited: 48
ICAM-1 orchestrates the abscopal effect of tumor radiotherapy
Yang Zhao, Ting Zhang, Yanpu Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 14
Open Access | Times Cited: 39
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Seung Mo Jin, Sang Nam Lee, Jung Eun Kim, et al.
Advanced Science (2021) Vol. 8, Iss. 19
Open Access | Times Cited: 35
Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
Ahmed Salah, Hao Wang, Yanqin Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
Construction and expression of multi-stage antigen fusion protein RPC4 vaccine for Mycobacterium tuberculosis and its immunogenicity analysis in combination with adjuvant DIMQ
Xiaochun Wang, Yun Xu, Qiangsen Zhong, et al.
Tuberculosis (2025), pp. 102635-102635
Closed Access
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
Xingwu Zhou, Moyuan Qu, Peyton Tebon, et al.
Advanced Science (2020) Vol. 7, Iss. 19
Open Access | Times Cited: 37
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors
Lillian L. Siu, Joshua Brody, Shilpa Gupta, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001095-e001095
Open Access | Times Cited: 36
Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy
Sang Nam Lee, Seung Mo Jin, Hong Sik Shin, et al.
Accounts of Chemical Research (2020) Vol. 53, Iss. 10, pp. 2081-2093
Closed Access | Times Cited: 35
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Miaoqin Chen, Shiman Hu, Yiling Li, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 33
Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
Valeria Lucarini, Ombretta Melaiu, Patrizia Tempora, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 433-433
Open Access | Times Cited: 30
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1065-1120
Open Access | Times Cited: 30
Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity
Stefano Persano, Pradip Das, Teresa Pellegrino
Cancers (2021) Vol. 13, Iss. 11, pp. 2735-2735
Open Access | Times Cited: 29
Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor‐Associated Macrophages for Cancer Immunotherapy
Di Wen, Tingxizi Liang, Guojun Chen, et al.
Advanced Science (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 22
Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
Sashi Debnath, Guiyang Hao, Bing Guan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7160-7160
Open Access | Times Cited: 20

Scroll to top